Life Sciences

OpenAI Acquires Orchestra Bio to Bring AI Agents into Drug Development

OpenAI has acquired Orchestra Bio, folding its AI agents for coordinating drug development programs into the Rosalind life-sciences suite to bridge research and program execution.